CASTELLUM INC (CTM) Stock Fundamental Analysis

NYSEARCA:CTM • US14838T2042

0.9246 USD
0 (-0.24%)
At close: Feb 20, 2026
0.9364 USD
+0.01 (+1.28%)
After Hours: 2/20/2026, 8:26:05 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to CTM. CTM was compared to 87 industry peers in the IT Services industry. CTM scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. CTM is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • In the past year CTM has reported negative net income.
  • CTM had a negative operating cash flow in the past year.
  • In the past 5 years CTM always reported negative net income.
  • In multiple years CTM reported negative operating cash flow during the last 5 years.
CTM Yearly Net Income VS EBIT VS OCF VS FCFCTM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 -5M -10M -15M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -12.95%, CTM is doing worse than 73.56% of the companies in the same industry.
  • CTM has a Return On Equity of -17.71%. This is in the lower half of the industry: CTM underperforms 64.37% of its industry peers.
Industry RankSector Rank
ROA -12.95%
ROE -17.71%
ROIC N/A
ROA(3y)-43.88%
ROA(5y)-36.34%
ROE(3y)-91.34%
ROE(5y)-85.43%
ROIC(3y)N/A
ROIC(5y)N/A
CTM Yearly ROA, ROE, ROICCTM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 -20 -40 -60 -80 -100

1.3 Margins

  • With a decent Gross Margin value of 39.27%, CTM is doing good in the industry, outperforming 63.22% of the companies in the same industry.
  • CTM's Gross Margin has declined in the last couple of years.
  • CTM does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 39.27%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.61%
GM growth 5YN/A
CTM Yearly Profit, Operating, Gross MarginsCTM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 20 -20 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. Health

2.1 Basic Checks

  • CTM does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, CTM has more shares outstanding
  • The debt/assets ratio for CTM has been reduced compared to a year ago.
CTM Yearly Shares OutstandingCTM Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 20M 40M 60M
CTM Yearly Total Debt VS Total AssetsCTM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

  • An Altman-Z score of 3.95 indicates that CTM is not in any danger for bankruptcy at the moment.
  • CTM has a better Altman-Z score (3.95) than 72.41% of its industry peers.
  • A Debt/Equity ratio of 0.13 indicates that CTM is not too dependend on debt financing.
  • The Debt to Equity ratio of CTM (0.13) is better than 68.97% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF N/A
Altman-Z 3.95
ROIC/WACCN/A
WACC9.56%
CTM Yearly LT Debt VS Equity VS FCFCTM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 5M 10M 15M 20M

2.3 Liquidity

  • A Current Ratio of 3.62 indicates that CTM has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 3.62, CTM belongs to the top of the industry, outperforming 83.91% of the companies in the same industry.
  • CTM has a Quick Ratio of 3.62. This indicates that CTM is financially healthy and has no problem in meeting its short term obligations.
  • The Quick ratio of CTM (3.62) is better than 83.91% of its industry peers.
Industry RankSector Rank
Current Ratio 3.62
Quick Ratio 3.62
CTM Yearly Current Assets VS Current LiabilitesCTM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 5M 10M 15M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 73.63% over the past year.
  • CTM shows a small growth in Revenue. In the last year, the Revenue has grown by 4.17%.
  • Measured over the past years, CTM shows a very strong growth in Revenue. The Revenue has been growing by 21.32% on average per year.
EPS 1Y (TTM)73.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%87.8%
Revenue 1Y (TTM)4.17%
Revenue growth 3Y21.32%
Revenue growth 5YN/A
Sales Q2Q%21.71%

3.2 Future

  • CTM is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 54.11% yearly.
  • CTM is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.65% yearly.
EPS Next Y125%
EPS Next 2Y54.11%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-5.85%
Revenue Next 2Y2.65%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CTM Yearly Revenue VS EstimatesCTM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M
CTM Yearly EPS VS EstimatesCTM Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 0 -0.05 -0.1 -0.15 -0.2

More info and screens

Find the best growth stocksShow best growing peers

2

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for CTM. In the last year negative earnings were reported.
  • CTM is valuated quite expensively with a Price/Forward Earnings ratio of 30.51.
  • The rest of the industry has a similar Price/Forward Earnings ratio as CTM.
  • CTM is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 28.06, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 30.51
CTM Price Earnings VS Forward Price EarningsCTM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CTM Per share dataCTM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 0.2 0.3 0.4 0.5

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as CTM's earnings are expected to grow with 54.11% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y54.11%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for CTM!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CASTELLUM INC

NYSEARCA:CTM (2/20/2026, 8:26:05 PM)

After market: 0.9364 +0.01 (+1.28%)

0.9246

0 (-0.24%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)11-07
Earnings (Next)02-26
Inst Owners8.97%
Inst Owner Change51.06%
Ins Owners8.68%
Ins Owner Change-12.21%
Market Cap87.48M
Revenue(TTM)47.60M
Net Income(TTM)-5.63M
Analysts80
Price Target3.57 (286.11%)
Short Float %4.84%
Short Ratio2.07
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)16.67%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)100%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.01%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 30.51
P/S 1.84
P/FCF N/A
P/OCF N/A
P/B 2.75
P/tB 5.83
EV/EBITDA N/A
EPS(TTM)-0.09
EYN/A
EPS(NY)0.03
Fwd EY3.28%
FCF(TTM)-0.02
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS0.5
BVpS0.34
TBVpS0.16
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -12.95%
ROE -17.71%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 39.27%
FCFM N/A
ROA(3y)-43.88%
ROA(5y)-36.34%
ROE(3y)-91.34%
ROE(5y)-85.43%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.61%
GM growth 5YN/A
F-Score4
Asset Turnover1.1
Health
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 5.57%
Cap/Sales 0.21%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.62
Quick Ratio 3.62
Altman-Z 3.95
F-Score4
WACC9.56%
ROIC/WACCN/A
Cap/Depr(3y)1.76%
Cap/Depr(5y)1.22%
Cap/Sales(3y)0.09%
Cap/Sales(5y)0.07%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)73.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%87.8%
EPS Next Y125%
EPS Next 2Y54.11%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)4.17%
Revenue growth 3Y21.32%
Revenue growth 5YN/A
Sales Q2Q%21.71%
Revenue Next Year-5.85%
Revenue Next 2Y2.65%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y35.76%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year260.67%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y148.93%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y149.46%
OCF growth 3YN/A
OCF growth 5YN/A

CASTELLUM INC / CTM FAQ

What is the fundamental rating for CTM stock?

ChartMill assigns a fundamental rating of 3 / 10 to CTM.


Can you provide the valuation status for CASTELLUM INC?

ChartMill assigns a valuation rating of 2 / 10 to CASTELLUM INC (CTM). This can be considered as Overvalued.


What is the profitability of CTM stock?

CASTELLUM INC (CTM) has a profitability rating of 1 / 10.


Can you provide the financial health for CTM stock?

The financial health rating of CASTELLUM INC (CTM) is 6 / 10.